Cadwalader allows sharing content.
Email to a friend or colleague:
From
To
Subject
Email Cadwalader Intellectual Property Group Chair and Partner Dorothy Auth shares her insights on the timing of Allele Biotech’s patent infringement lawsuits against Pfizer and Regeneron in connection with their use of Allele’s patented molecules to develop COVID-19 treatments. Dorothy also comments on the case’s specific issue of how research tools are used in developing pharmaceutical products. https://www.cadwalader.com/news/recent-press/lawyers-ponder-impact-of-covid-cocktail-lawsuit